HCP life science innovation ApS: Financial statements 2022
CVR: 40003665
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
HCP life science innovation ApS (CVR 40003665) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -471,264 and a net result of DKK -470,213 compared with DKK -508,858 the year before. Equity in the 2022 report amounted to DKK 117,952. The solvency ratio was 8.1%.
- Gross Profit
- DKK -471,264
- Profit/Loss
- DKK -470,213
- Equity
- DKK 117,952
- Total Assets
- DKK 1,454,138
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -471K | -470K | 118K | - |
| 2021 | - | -590K | -509K | 88K | - |
| 2020 | - | -201K | -199K | 97K | - |
Official annual report
Keep an eye on HCP life science innovation ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout HCP life science innovation ApS
HCP life science innovation ApS is a Danish company of the type Anpartsselskab based in Brande, founded in 2018. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Hans-Christoph Paul. The company is owned by HCP HOLDING ApS. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK 9,955 and a net result of DKK 34,931 compared with DKK -123,484 the year before. Equity in the 2026 report amounted to DKK 150,057.
